Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
103.00
+0.93 (0.91%)
Dec 15, 2025, 3:07 PM EST - Market open
Guardant Health Market Cap
Guardant Health has a market cap or net worth of $13.27 billion as of December 15, 2025. Its market cap has increased by 212.50% in one year.
Market Cap
13.27B
Enterprise Value
14.12B
1-Year Change
212.50%
Ranking
Category
Stock Price
$103.00
Market Cap Chart
Since October 4, 2018, Guardant Health's market cap has increased from $2.69B to $13.27B, an increase of 393.22%. That is a compound annual growth rate of 24.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 13.15B | 248.40% |
| Dec 31, 2024 | 3.77B | 14.96% |
| Dec 29, 2023 | 3.28B | 17.84% |
| Dec 30, 2022 | 2.79B | -72.60% |
| Dec 31, 2021 | 10.17B | -21.09% |
| Dec 31, 2020 | 12.88B | 75.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 946.90B |
| Johnson & Johnson | 516.50B |
| AbbVie | 401.21B |
| UnitedHealth Group | 309.37B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 247.73B |
| Novo Nordisk | 224.22B |